Global Hemodialysis Vascular Grafts Market by Raw Material (Biological Materials, Polytetrafluoroethylene, Polyester, Polyurethane) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In 2018, the global market for hemodialysis and vascular grafts was worth USD 209.1 millions. The market is expected to grow at a CAGR 4.1 percent over the forecast period. Market growth is expected to be driven by the growing prevalence of renal diseases, the increasing adoption of biological access transplants, and technological advances in these products.

Due to a shortage of kidney donors, hemodialysis is becoming more popular for patients with chronic kidney disease (CKD). Accordingly, there will be an increase in demand for hemodialysis and vascular grafts during the forecast period.

Due to a large unmet patient population in developing economies, CKD is often not diagnosed and treated promptly. There are also comparatively poor healthcare facilities and unavailability for suitable donors. Because of the availability of more affordable options, such as vascular access transplants, kidney transplantation is preferred over hemodialysis in developing countries.

The market is expected to grow as more people are aware of CKD in these countries over the forecast period. India Renal Foundation, a non-governmental organization that conducts awareness programs to prevent kidney disease, has conducted approximately 15,000 programs so far.

Long-term central vein catheterization is required for dialysis patients. Patients also have the option of arteriovenous transplant (AVG) In cases where patients' superficial veins are exhausted by continuous hemodialysis, this AVG can be used. Although synthetic polytetrafluoroethylene (PTFE) grafts are becoming popular worldwide, they have several disadvantages such as steal syndrome, high risk of infection, and long patency. Biological access grafts offer greater patient benefits than synthetic - such as a lower risk of infection, and fewer rejections.

Raw Material Insights

On the basis of raw material, the market has been segmented into polyester, polytetrafluoroethylene, polyurethane, and biological materials. The polytetrafluoroethylene segment dominated the market and accounted for 45.0% of the overall revenue in 2018. This segment accounted for 45.0% of the overall revenue in 2018. It is known for its superior adhesion and flexibility compared with other materials, and similar patency to other synthetic products.

Hemodialysis access products manufactured using single component polyester-polyurethane are hydrolytically unstable after implantation. C. R. Bard, Inc. developed Vectra for vascular access, which is composed of polyetherurethaneurea and siloxane that contains surface-modifying additive. The product is fast in hemostasis and can be used within one to five minutes after needle withdrawal. The launch of new products will contribute to the expansion of the overall market for hemodialysis and vascular grafts.

The human saphenous veins, as well as other tissue-engineered materials, are used to create biological vascular access grafts. These grafts have a higher rate of infection, greater patency and longer durability than synthetic ones. These grafts can be used to treat vascular graft infection and patients at risk for AV access infections. This segment will see a 3.3% CAGR over the forecast period.

Regional Insights

In 2017, North America was the largest revenue share worldwide. The primary growth stimulants in the region market are the higher healthcare spending as a percentage GDP, the preference for tissue engineered vascular access grafts and the increased number of patients suffering from CKD.

In 2018, the U.S. alone contributed more than 27.0% to global market revenues. The market is experiencing a rise in CKD patients as well as increased penetration of synthetic hemodialysis vascular accessibility grafts. Europe accounted for approximately 24.0% in total revenue in 2017. This is due to the increased preference for hemodialysis over peritoneal. The regional market is growing because of the acceptance of these products for hemoodialysis.

Asia Pacific is expected to experience the highest CAGR at 6.6% between 2018-2025. This is due to increasing numbers of patients with CKD, insufficient kidney donors and rising healthcare costs. The market is expected to see lucrative growth opportunities in Asia Pacific during the forecast period due to the rising number of dialysis procedures.

Market Share Insights & Key Companies

This market is dominated by a few companies, such as W.L. C. R. Bard, Inc., Terumo Medical Corporation, LeMaitre Vascular, Inc., and Getinge AB are some of the other companies operating in this market. Vascular Genesis, InnAVasc Medical, Inc., CryoLife, Inc., Merit Medical Systems, Inc., and Proteon Therapeutics, Inc. are some of the other companies that operate in this market. Due to the launch of cost-effective, technologically advanced grafts, the competition is expected to rise in this market.

Hemodialysis Vascular Grafts Market Report Scope

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional, or country level and analyzes industry trends for each sub-segment between 2014 and 2025. Grand View Research segmented the global market for hemodialysis and vascular grafts based on raw material type, region, and other factors.

• The Raw Material Outlook (Revenue USD Millions, 2014-2025)

  • Polyester

  • Polytetrafluoroethylene

  • Polyurethane

  • Biological Materials

• Regional Outlook (Revenue USD Million, 2014-2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

These are the most frequently asked questions about this report

b. Global hemodialysis vascular transplants market was valued at USD 217.5 million in 2019, and is forecast to grow to USD 227.03 millions in 2020.

b. Global hemodialysis vascular transplants market is expected grow at a compound annual rate of 4.1% between 2019 and 2025, reaching USD 276.48 billion in 2025.

b. Polytetrafluoroethylene dominated the hemodialysis vascular grafts market with a share of 44.3% in 2019.

b. W.L. Gore & Associates, C. R. Bard, Inc., Terumo Medical Corporation, LeMaitre Vascular, Inc., and Getinge AB.

b. The market for hemodialysis and vascular transplants is growing due to the rising prevalence of renal diseases, the adoption of biological accessgrafts, as well as technological advances in hemodialysis.

Up Market Research published a new report titled “Hemodialysis Vascular Grafts Market research report which is segmented by Raw Material (Biological Materials, Polytetrafluoroethylene, Polyester, Polyurethane), By Players/Companies Inc; Terumo Medical Corporation; LeMaitre Vascular, WL Gore & Associates; C R Bard, Inc; and Getinge AB”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Hemodialysis Vascular Grafts Market Report Segments:

The market is segmented by Raw Material (Biological Materials, Polytetrafluoroethylene, Polyester, Polyurethane).

Hemodialysis Vascular Grafts Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hemodialysis Vascular Grafts Market

Overview of the regional outlook of the Hemodialysis Vascular Grafts Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Hemodialysis Vascular Grafts Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Hemodialysis Vascular Grafts Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Biological Materials

                2. Polytetrafluoroethylene

                3. Polyester

                4. Polyurethane

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hemodialysis Vascular Grafts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Hemodialysis Vascular Grafts Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.